Jones Financial Companies
ABUS icon

Jones Financial Companies’s Arbutus Biopharma ABUS Stock Holding History

Jones Financial Companies’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Hold
830
– – ﹤0.01% 4225
2026
Q1 		$3.56K Hold
830
– – ﹤0.01% 3969
2025
Q4 		$3.99K Hold
830
– – ﹤0.01% 3586
2025
Q3 		$3.66K Hold
830
– – ﹤0.01% 3486
2025
Q2 		$2.6K Sell
830
-872
-51% -$2.9K ﹤0.01% 3377
2025
Q1 		$5.96K Hold
1,702
– – ﹤0.01% 2899
2024
Q4 		$5.57K Buy
1,702
+872
+105% +$3.21K ﹤0.01% 2721
2024
Q3 		$3.18K Hold
830
– – ﹤0.01% 2563
2024
Q2 		$2.56K Buy
+830
New +$2.49K ﹤0.01% 2105

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jones Financial Companies's ABUS Position: Q2 2026 in Review

Jones Financial Companies held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 830 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4225.

Jones Financial Companies first reported a position in ABUS in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.96K in Q1 2025. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Jones Financial Companies held 830 shares of Arbutus Biopharma worth $3.8K as of Q2 2026.
  • Jones Financial Companies left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4225 holding.
  • Jones Financial Companies first reported a position in Arbutus Biopharma in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Arbutus Biopharma position peaked at $5.96K in Q1 2025.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.